InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Wilhoit Scott L., Directeur Commercial. Officer active across 2 companies, notably Strongbridge Biopharma plc. Aggregated, 2 filings have been recorded. History available since 1 October 2021. The latest transaction was filed on 1 October 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Scott L. Wilhoit is the Chief Commercial Officer of Strongbridge Biopharma plc. He is responsible for the company's commercial strategy and business development. His role is essential in ensuring revenue growth and market expansion. Scott brings expertise in commercial strategy and product development.